Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Financing Activities: 2021-2025

Historic Cash from Financing Activities for MDxHealth (MDXH) over the last 4 years, with Sep 2025 value amounting to -$1.7 million.

  • MDxHealth's Cash from Financing Activities fell 105.01% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.6 million, marking a year-over-year increase of 0.30%. This contributed to the annual value of $44.6 million for FY2024, which is 38.16% up from last year.
  • MDxHealth's Cash from Financing Activities amounted to -$1.7 million in Q3 2025, which was up 85.61% from -$11.7 million recorded in Q2 2025.
  • MDxHealth's Cash from Financing Activities' 5-year high stood at $33.6 million during Q3 2024, with a 5-year trough of -$11.7 million in Q2 2025.
  • In the last 2 years, MDxHealth's Cash from Financing Activities had a median value of $884,000 in 2024 and averaged $8.5 million.
  • Per our database at Business Quant, MDxHealth's Cash from Financing Activities tumbled by 105.91% in 2022 and then surged by 105.01% in 2025.
  • Over the past 4 years, MDxHealth's Cash from Financing Activities (MRQ) stood at $26.8 million in 2021, then plummeted by 106.01% to -$1.6 million in 2022, then skyrocketed by 154.80% to $884,000 in 2024, then crashed by 290.27% to -$1.7 million in 2025.
  • Its Cash from Financing Activities stands at -$1.7 million for Q3 2025, versus -$11.7 million for Q2 2025 and $21.5 million for Q1 2025.